Public Health Funding Restoration Act
HB1715, titled the Public Health Funding Restoration Act, would amend section 4002 of the Affordable Care Act to fully fund the federal Prevention and Public Health Fund at $2 billion annually beginning in fiscal year 2026 and continuing each year thereafter. The bill’s findings state that the Fund was intended to support sustained national investment in prevention and public health programs, including efforts to reduce infectious disease, injuries, chronic disease, and other preventable health problems.
The bill emphasizes that the Fund supports a wide range of activities at the federal, state, local, tribal, and territorial levels, including tobacco cessation, nutrition, mental health, childhood lead poisoning prevention, elder care initiatives, and immunizations. It also cites cost-savings arguments, asserting that prevention spending reduces future health care costs and helps strengthen public health systems’ ability to respond to outbreaks, pandemics, and other threats. In practical terms, the bill would restore and lock in a higher annual funding level for the Prevention and Public Health Fund by replacing the current statutory funding schedule with a flat $2 billion amount starting in FY2026.
The bill would directly affect the Affordable Care Act’s Prevention and Public Health Fund provision, increasing the guaranteed annual appropriation level and reinforcing the role of prevention in federal health policy. It would likely benefit the Centers for Disease Control and Prevention and state, local, tribal, and territorial health departments that rely on these funds for prevention, surveillance, vaccination, and community health initiatives. No other statutes are amended in the text.
The available context shows generally supportive framing, with the bill introduced by a large group of Democratic sponsors and no recorded committee debate or votes in the provided materials. The findings language is strongly pro-prevention and pro-public-health, presenting the bill as a cost-saving and readiness measure. Because there are no transcripts or votes, there is no documented opposition in the supplied record, but the main policy issue implicit in the bill is the level of federal spending and the prioritization of prevention funding within the health budget.
HB1715 would amend the Affordable Care Act’s Prevention and Public Health Fund to set annual funding at $2 billion for fiscal year 2026 and beyond, replacing the existing funding formula. This would increase and stabilize federal support for prevention-oriented public health programs, with downstream effects on CDC activities and grants or support to state, local, tribal, and territorial health departments. Affected parties would include public health agencies, immunization programs, and community-based prevention initiatives that receive or depend on these funds.
The bill appears to have a strongly favorable tone among its sponsors and in its findings, which frame prevention funding as essential, cost-effective, and necessary for public health preparedness. The sponsor list is broad and entirely Democratic in the materials provided, and there are no recorded votes or committee remarks indicating opposition or amendment activity. Overall, the available context suggests support for restoring and protecting public health funding rather than controversy in the documented record.
No committee transcript or vote record was provided, so there is no direct evidence of debate or formal opposition in the supplied materials. The likely point of contention, based on the bill text, is fiscal: whether Congress should commit to a permanent $2 billion annual funding level for the Prevention and Public Health Fund. Supporters emphasize prevention, vaccination, chronic disease reduction, and long-term savings, while potential critics would likely focus on federal spending levels, budget priorities, and whether the Fund should be expanded or maintained at that amount.